Biopharma News : Biopharma and Pharma news from all around the world :
- Optomec Customer Carnegie Mellon Develops 10-Second COVID Test
- Join the Heart Failure Society of America for the First Virtual Annual Scientific Meeting
- CDISC Names Dr. Maria Im Hee Shin Chair of Korea CDISC Coordinating Committee
- Global Cell Culture Market and Technology Forecast 2020-2028 – Global Market Forecast to Reach USD 48 Billion for 2028 – ResearchAndMarkets.com
- EOS imaging Reports Its 2020 Half-year Financial Results
- Javelin Biotech Aims to Develop Industry-Leading “Organ-on-a-Chip” Predictive Pharmacokinetics Platform in Collaboration with Pfizer Inc.
- Pace International LLC Announces Senior Level Leadership Changes
- Valent BioSciences Announces Creation of New Chief Commercial Officer Position and Other Organizational and Reporting Changes to Drive Growth
- Global Radiopharmaceuticals in Nuclear Medicine Market to surpass US$ 11,504.8 Mn by 2027, Says Coherent Market Insights (CMI)
- OncoImmune Launches First-in-human Clinical Trial for ONC-392 – The anti-CTLA-4 Antibody that Preserves CTLA4 Recycling for Safer and More Effective Immunotherapy
- Global Transplant Diagnostics Market Trajectory & Analytics, 2020-2027: U.S. Market is Estimated at $970.2 Million, While China is Forecast to Grow at 9.4% CAGR – ResearchAndMarkets.com
- P360 Adds Advanced Artificial Intelligence Capabilities to Its Sales Enablement Platform BirdzAI
- Global Cell Culture Monitoring Biosensors Market to Surpass US$ 632.0 Mn by 2027, Says Coherent Market Insights (CMI)
- Escient Pharmaceuticals Appoints Veena Viswanath, Ph.D., as VP of Translational Biology and Drug Discovery
- Celmatix Announces New Advisory Board
- PharmaCyte Biotech Continues to Engage the FDA During 30-Day Comment Period
- CB Therapeutics Achieves Major Breakthroughs in Downstream Processing and Purification, Paving the Way for Low-cost Cannabinoids, Tryptamines, and Their Analogs
- ValuCare Center Named Health Mart Pharmacy of the Year
- Stella Diagnostics Selected as Buzz of BIO Winner for the 2020 BIO Investor Forum Digital
- Libra Therapeutics Launches with $29 Million Series A to Develop Novel Therapeutics for Neurodegenerative Diseases
- Catabasis Pharmaceuticals to Present During the Virtual 25th International Congress of the World Muscle Society
- CILcare-CBSET Nominated for the Prestigious PRIX Galien Medstartup Award in the ‘Best Collaboration Dedicated to the Developing or Underserved Populations Worldwide’ Category
- NantHealth Enhances Interoperability of the NaviNet Open Platform With Expanded API Capabilities
- Veeva and Bioforum Partner with RedHill Biopharma to Maximize Value of Opaganib Phase 2/3 COVID-19 Clinical Data
- FDA Accepts Supplemental New Drug Application for Pfizer’s XALKORI® (crizotinib) for the Treatment of Pediatric ALK-positive Anaplastic Large Cell Lymphoma
- Humanigen Announces Thermo Fisher Partnership to Expand Manufacturing for COVID-19 Therapeutic Candidate Lenzilumab
- Sun Pharmaceutical Industries, Inc. Issues Voluntary Nationwide Recall of RIOMET ER™ (metformin hydrochloride for extended-release oral suspension) Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
- COVID-19 Recovery Analysis: Pharmaceutical Traceability Market | Growing Concerns Over Counterfeit Drugs to Boost the Market Growth | Technavio
- FDA Grants RMAT Designation to MultiStem Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome
- Europe $11.65 Billion Antibiotics Markets, Analysis 2015-2019 & Forecasts 2020-2030 – ResearchAndMarkets.com
Biotech – Biopharma News!
- Relief partner NeuroRx submits request for Emergency Use Authorization for RLF-100(TM) (aviptadil) in the treatment of patients with Critical COVID-19 and Respiratory Failure who have exhausted approved therapy
- Formycon Announces Half-Year Results for 2020
- MagForce AG Publishes Shareholder Letter
- Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
- Eckert & Ziegler to Run Tumor Radiation Business Through TCL Healthcare Equipment
- AEVIS VICTORIA SA: Half-year results 2020 – Good overall resilience to COVID-19 crisis
- MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas (news with additional features)
- MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer (news with additional features)
- Original-Research: MPH Health Care (von First Berlin Equity Research GmbH)
- Positive Results from Adrenomed’s AdrenOSS-2 Phase II trial evaluating Adrecizumab (HAM8101) in Septic Shock presented during e-ISICEM
- AMP German Cannabis Group Hires Experienced Sales Director from Canopy Growth
- Newron announces half-year 2020 results
- Relief Reports Half-Year 2020 Results
- Data from Adrenomed’s AdrenOSS-2 trial with Adrecizumab in Septic Shock to be presented during e-ISICEM
- 4basebio AG: 4basebio comments on the takeover bid of Sparta AG
- EVOTEC AND BIOASTER PARTNER TO BUILD A TECHNOLOGY AND INNOVATION HUB IN LYON
- Heidelberg Pharma Receives Milestone Payment from Partner Magenta
- Polyphor to present at the H.C. Wainwright Global Investment Conference
- Drägerwerk AG & Co. KGaA: Dräger agrees with the federal government to end the delivery of ventilators
- Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE on the production of a COVID-19 vaccine
- Dermapharm Holding SE signs cooperation and delivery agreement with BioNTech SE
- Heidelberg Pharma Announces Participation at Various Conferences
- PharmaSGP with strong revenue and EBIT growth and increased profitability in the first half of 2020
- Biotest AG: Biotest is one of the first plasma protein manufacturers to provide digital package leaflets for all products
- Dermapharm publishes Half-Year Financial Report 2020 and confirms growth course despite corona pandemic
- Zur Rose and KPT together launch digital medicines assistant Medi+
- RHÖN-KLINIKUM Aktiengesellschaft: Partnership with Asklepios Strengthens Medical Care at the University Hospitals in Giessen and Marburg
- Original-Research: HAEMATO AG (von First Berlin Equity Research GmbH)
- Medios AG: Inclusion to the SDAX
- Relief Appoints Gilles Della Corte, M.D. as Chief Medical Officer
- Saniona announces outcome of warrant exercise
- Guerbet: 2020 Half-year results
- Nicox Selects 0.1% NCX 470 Dose in Adaptive Stage of Mont Blanc Phase 3 Glaucoma Trial
- JRSIS Health Care Corporation Spokesperson, Mary Xing, Discusses the Business Model and Markets for the Company in a New Audio Interview at SmallCapVoice.com
- Capricor Therapeutics to Present Results from the HOPE-2 Trial with CAP-1002 in Duchenne Muscular Dystrophy at the International World Muscle Society Virtual Congress 2020
- Recce Pharmaceuticals Completes Capital Raising of $27.95 Million
- Cognoa Seeks FDA Clearance for Breakthrough Digital Autism Diagnostic Device After Successful Pivotal Study
- HALE Sports and Queens University of Charlotte Partner to Provide Support and Empowerment for 650 Virtual Student Athletes
- New Study Shows AI-Powered Diabits App Can Improve Blood Glucose Control
- Teligent Announces Completion of Series D Convertible Note Exchange
- Helsinn supports the PhD program 2020-2021 of the Institute of Oncology Research (IOR) of the Faculty of Biomedical Sciences at the Università della Svizzera italiana (USI)
- Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD
- Helsinn supports the PhD program 2020-2021 of the Institute of Oncology Research (IOR) of the Faculty of Biomedical Sciences at the Università della Svizzera italiana (USI)
- GW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
- Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD
- GW Pharmaceuticals receives Australian Therapeutic Goods Administration (TGA) approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
- CENTOGENE Opens Walk-In COVID-19 Testing Facility at Düsseldorf Airport
- Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program
- Addex to Present at the Investora Conference
- Adicet Bio, Inc. Determines Not to Proceed with Public Offering of Common Stock
- Predictive Oncology Secures License for an Additional 71 Unique Ovarian Cancer Cell Lines from Ximbio, Cancer Research UK’s Premier Reagents Distributor
- Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen
- MacroGenics Announces Publication of Flotetuzumab Interim Phase 1/2 Clinical Trial Results in Blood
- Zogenix, Inc. Announces Proposed Convertible Senior Notes Offering
- GENFIT To Announce First Half-Year 2020 Financial Results and New Corporate Strategy on September 30, 2020
- Riverside Regional Jail Authority Selects Corizon Health
- Grey Cloak Tech Inc. Files for Name Change to Healthy Extracts Inc.
- Sanofi and GSK sign agreements with the Government of Canada to supply up to 72 million doses of adjuvanted COVID-19 vaccine
- Eurobio Scientific launches a first rapid diagnostic test for the detection of the SARS CoV-2 virus antigen
- Agile Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
.
Biotech – Biopharma News!
Every day, Biotech 365 brings you information about Biotech Companies, Biopharma News, Biotech Tools, Bioinformatic tips and BioMarketplace ! To receive weekly notifications about Biopharma News and the last articles added to Biotech 365, please register to our Newsletter. And please Follow Biotech 365 on Twitter ( https://twitter.com/Biotech365 ) and LinkedIn (www.linkedin.com/company/biotech-365 ) … thanks !!!
Biotech 365 is an independent website, sharing information and news about Biotech Companies, Biotechnology, Biopharma News and Pharma News. If you want to contribute, you’re welcome! Please do not hesitate to Contact us ! Thanks !!!
Lots of very interesting and promising Biopharma Companies emerge everyday around the world. Looking for new partners? For new suppliers or clients? Biotech-365.com will present you lots of Biotech companies from all around the world and keep you informed about the last Biopharma news ! Don’t lose your time searching for new Biotech or Biopharma partners! The most interesting ones are on Biotech-365.com !
You want to propose a Biotech Company, a Biotech Tool or a Bioinformatic software to be presented on Biotech-365.com? Please use our Contact page ! Interested in becoming our partner? Please Contact us ! Thanks !!! If you want to promote your Biotech company or Biopharma Company on our website, please check our Offers! Biotech 365 brings you every day the more interesting information about Biopharma News, Biotech Companies and Biotech Tools! Enjoy them with a good coffee and share with your teammates!
Biopharma News – Pharma News
Biotech 365 : daily news about Biotech and Biopharma
Sources for this page of Biopharma News : biopharma-reporter.com and worldpharmanews and pharmatimes.com and drugs.com and fiercepharma.com and scripintelligence.com and PR Newswire and Business Wire. Please visit all this very interesting websites ! Thanks !
Biopharma News – Pharma News
Biopharma News – Pharma News